Blog | HemaCare

Telomerase Inhibition Could Be a Promising Approach for Disorders of Platelets

Nov 4, 2015 1:00:45 PM / by Karina Palomares posted in essential thrombocythemia, myeloproliferative neoplasms, Imetelstat, Platelets, research, telomerase

0 Comments

Recent findings of a phase II clinical trial of imetelstat, a telomerase inhibitor, demonstrate that it could be a promising treatment approach for patients with essential thrombocythemia, which raises platelets to dangerous levels.

Myeloproliferative neoplasms are a group of disorders caused by an overproduction of a particular blood cell type. For example, essential thrombocythemia (ET) causes an abnormal increase in the number of platelets produced in the blood and bone marrow. Although most patients have a normal life expectancy, ET may develop into acute myeloid leukemia. Currently available drugs help manage symptoms and offer protection from heart attack or strokes, but more treatment options are necessary for those patients who are not responsive or who experienced adverse side effects.

Read More

Reporting from the AABB: What’s the Future of Therapeutic Apheresis?

Dec 17, 2014 1:00:30 PM / by James Sanchez posted in Cell Therapy, emerging trends, Independent validation, Innovation, Platelets, research

0 Comments

Standard apheresis equipment is soon to be supplanted. What are the advantages in the next generation?

Read More

Stem Cells for Manfacturing Transfusion Medicine Supplies

Sep 29, 2014 1:00:45 PM / by Daisy posted in CD133+, CD34, megakaryocytes, myeloid, Platelets, research

0 Comments

Growing platelets from hematopoietic stem cells may be a small step in science, but a leap in transfusion medicine

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts